---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-014223"
form_type: "8-K"
ticker: "RMD"
cik: "0000943819"
company_name: "RESMED INC"
filed_at: "2024-01-24T23:59:59+00:00"
generated_at: "2026-06-06T19:44:50.239602+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# ResMed Q2 FY2024 revenue $1.16B (+12% YoY); non-GAAP EPS $1.88 (+13%)

## Summary
- Revenue $1,162.8M (+12% YoY, +11% constant currency); GAAP op profit down 2%, non-GAAP op profit up 20% to $365.5M.
- GAAP diluted EPS $1.42 (-7%); non-GAAP diluted EPS $1.88 (+13%), driven by revenue growth and cost discipline.
- Board declared $0.48/share quarterly cash dividend with record date Feb 8, payable March 14.
- Resumed share repurchase program; repurchased $50M of common stock during the quarter.
- Gross margin contracted 50 bps to 55.6% GAAP; non-GAAP gross margin improved 10 bps to 56.9%.

## SEC filing metadata
- accession: 0001193125-24-014223
- form_type: 8-K
- ticker: RMD
- cik: 0000943819
- company_name: RESMED INC
- filed_at: 2024-01-24T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/943819/000119312524014223/0001193125-24-014223-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/943819/000119312524014223/d685328d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-014223
- JSON: https://secwatch.observer/filing/0001193125-24-014223.json
- Plain text: https://secwatch.observer/filing/0001193125-24-014223.txt

## Key facts
- Earnings Releases
  RESMED INC reported quarter ended December 31, 2023 results: revenue $1,162.8, net income $208.8, EPS $1.42.
  - Period: quarter ended December 31, 2023
  - Revenue: $1,162.8
  - Net income: $208.8
  - EPS: $1.42
  - Result: reported results
  source text: and Operating Metrics Unaudited; $ in millions, except for per share amounts Three Months Ended December 31, 2023 December 31, 2022 % Change Constant Currency (A) Revenue $ 1,162.8 $ 1,033.7 12 % 11 % Gross margin 55.6 % 56.1 % (1 ) Non-GAAP gross margin (B) 56.9 % 56.8 % — Selling, general, and administrative expenses 222.2 211.7 5 4 Research and
  evidence_url: https://www.sec.gov/Archives/edgar/data/943819/000119312524014223/0001193125-24-014223-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.